' Ultralow-Risk ' Breast Cancers Can Skip Endocrine Therapy ' Ultralow-Risk ' Breast Cancers Can Skip Endocrine Therapy
' Ultralow-risk breast cancer ' is a not commonly used term, but a new study suggests that patients with such cancers could receive less treatment.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Health | Hematology | Study